ENGN · Categories · Form 4

ENGN - SEC Form 4 insider transactions

enGene Therapeutics Inc. (ENGN) sec form 4 insider transactions - real-time wire coverage filtered to Form 4 only.

Recent Form 4 for ENGN

• 132d
  SEC Form 4 filed by Chief Scientific Officer Cheung Anthony Tzeyew

  4 - enGene Holdings Inc. (0001980845) (Issuer)
• 132d
  SEC Form 4 filed by Chief Legal Ofc. and Corp Secy Giguere Lee

  4 - enGene Holdings Inc. (0001980845) (Issuer)
• 132d
  SEC Form 4 filed by Chief Strategy & Ops. Ofc Nichols Alexander Julian

  4 - enGene Holdings Inc. (0001980845) (Issuer)
• 132d
  SEC Form 4 filed by Chief Financial Officer Daws D. Ryan

  4 - enGene Holdings Inc. (0001980845) (Issuer)
• 132d
  SEC Form 4 filed by CEO & President Cooper Ronald Harold Wilfred

  4 - enGene Holdings Inc. (0001980845) (Issuer)
• 132d
  SEC Form 4 filed by Chief Technology Officer Connolly Joan

  4 - enGene Holdings Inc. (0001980845) (Issuer)
• 132d
  SEC Form 4 filed by Chief Regulatory Officer Boyd Matthew Ross

  4 - enGene Holdings Inc. (0001980845) (Issuer)
• 132d
  SEC Form 4 filed by Chief Development Officer Buck Jill

  4 - enGene Holdings Inc. (0001980845) (Issuer)
• 257d
  SEC Form 4 filed by Chief Medical Officer Sweiti Hussein

  4 - enGene Holdings Inc. (0001980845) (Issuer)
• 336d
  SEC Form 4 filed by Chief Regulatory Officer Boyd Matthew Ross

  4 - enGene Holdings Inc. (0001980845) (Issuer)
• 340d
  SEC Form 4 filed by Director Astley-Sparke Philip

  4 - enGene Holdings Inc. (0001980845) (Issuer)
• 340d
  SEC Form 4 filed by Director Heffernan Michael Thomas

  4 - enGene Holdings Inc. (0001980845) (Issuer)
• 340d
  SEC Form 4 filed by Director Grossman William

  4 - enGene Holdings Inc. (0001980845) (Issuer)
• 340d
  SEC Form 4 filed by Chief Development Officer Buck Jill

  4 - enGene Holdings Inc. (0001980845) (Issuer)
• 364d
  SEC Form 4 filed by Director Zoth Lota S.

  4 - enGene Holdings Inc. (0001980845) (Issuer)
• 364d
  SEC Form 4 filed by Chief Global Comm. Ofc. Pott Amy

  4 - enGene Holdings Inc. (0001980845) (Issuer)
• 364d
  SEC Form 4 filed by Director Joustra Wouter

  4 - enGene Holdings Inc. (0001980845) (Issuer)
• 364d
  SEC Form 4 filed by Director Hastings Paul J

  4 - enGene Holdings Inc. (0001980845) (Issuer)
• 364d
  SEC Form 4 filed by Director Glickman Richard M

  4 - enGene Holdings Inc. (0001980845) (Issuer)
• 364d
  SEC Form 4 filed by Director Brunk Gerald A

  4 - enGene Holdings Inc. (0001980845) (Issuer)
• 364d
  SEC Form 4 filed by Director Bos Jasper

  4 - enGene Holdings Inc. (0001980845) (Issuer)
• 500d
  SEC Form 4 filed by Chief Medical Officer Pruthi Raj Som

  4 - enGene Holdings Inc. (0001980845) (Issuer)
• 500d
  SEC Form 4 filed by Chief Strategy & Ops. Ofc Nichols Alexander Julian

  4 - enGene Holdings Inc. (0001980845) (Issuer)
• 500d
  SEC Form 4 filed by Chief Legal Ofc. and Corp Secy Giguere Lee

  4 - enGene Holdings Inc. (0001980845) (Issuer)
• 500d
  SEC Form 4 filed by Chief Financial Officer Daws D. Ryan

  4 - enGene Holdings Inc. (0001980845) (Issuer)
• 500d
  SEC Form 4 filed by Chief Scientific Officer Cheung Anthony Tzeyew

  4 - enGene Holdings Inc. (0001980845) (Issuer)
• 500d
  SEC Form 4 filed by CEO & President Cooper Ronald Harold Wilfred

  4 - enGene Holdings Inc. (0001980845) (Issuer)
• 601d
  SEC Form 4 filed by Chief Scientific Officer Cheung Anthony Tzeyew

  4 - enGene Holdings Inc. (0001980845) (Issuer)
• 601d
  SEC Form 4 filed by Chief Technology Officer Connolly Joan

  4 - enGene Holdings Inc. (0001980845) (Issuer)
• 689d
  SEC Form 4 filed by Chief Medical Officer Pruthi Raj Som

  4 - enGene Holdings Inc. (0001980845) (Issuer)
• 691d
  SEC Form 4 filed by Chief Executive Officer Cooper Ronald Harold Wilfred

  4 - enGene Holdings Inc. (0001980845) (Issuer)
• 727d
  SEC Form 4 filed by Director Zoth Lota S.

  4 - enGene Holdings Inc. (0001980845) (Issuer)
• 727d
  SEC Form 4 filed by Director Hastings Paul J

  4 - enGene Holdings Inc. (0001980845) (Issuer)
• 727d
  SEC Form 4 filed by Director Joustra Wouter

  4 - enGene Holdings Inc. (0001980845) (Issuer)
• 727d
  SEC Form 4 filed by Director Glickman Richard M

  4 - enGene Holdings Inc. (0001980845) (Issuer)
• 727d
  SEC Form 4 filed by Director Bos Jasper

  4 - enGene Holdings Inc. (0001980845) (Issuer)
• 727d
  SEC Form 4 filed by Director Brunk Gerald A

  4 - enGene Holdings Inc. (0001980845) (Issuer)
• 747d
  Glickman Richard M exercised 120 shares at a strike of $0.89, increasing direct ownership by 0.49% to 24,675 units (SEC Form 4)

  4 - enGene Holdings Inc. (0001980845) (Issuer)
• 784d
  Fonds De Solidarite Des Travailleurs Du Quebec sold $787,981 worth of shares (52,529 units at $15.00), decreasing direct ownership by 2% to 3,036,153 units (SEC Form 4)

  4 - enGene Holdings Inc. (0001980845) (Issuer)
• 812d
  SEC Form 4 filed by Zoth Lota S.

  4 - enGene Holdings Inc. (0001980845) (Issuer)
• 817d
  Cheung Anthony Tzeyew exercised 52,940 shares at a strike of $0.89, increasing direct ownership by 106% to 102,873 units (SEC Form 4)

  4 - enGene Holdings Inc. (0001980845) (Issuer)
• 818d
  SEC Form 4 filed by Giguere Lee

  4 - enGene Holdings Inc. (0001980845) (Issuer)
• 845d
  Brunk Gerald A was granted 800,000 shares (SEC Form 4)

  4 - enGene Holdings Inc. (0001980845) (Issuer)
• 845d
  Lumira Capital Investment Management Inc. was granted 800,000 shares (SEC Form 4)

  4 - enGene Holdings Inc. (0001980845) (Issuer)

Other ENGN categories

• 8-K
• 10-K
• 10-Q
• S-1
• 13D
• 13G
• Form 3
• Form 5
• DEF 14A
• M&A
• Earnings
• Dividends